Actividad cicatrizante in vivo del polvo carbonizado de Punica granatum Linn y Eichhornia crassipes / In vivo healing activity of the charred powder of Punica granatum Linn and Eichhornia crassipes

Introducción: Las especies vegetales constituyen el remedio primero a los problemas de salud que aquejan a las personas. La granada es rica en ácido ascórbico, mejora la barrera epidérmica y reduce la contracción de las heridas. La flor de agua posee actividad antibacteriana. Objetivo: Evaluar el efecto cicatrizante del polvo carbonizado de Punica granatum Linn (granada) y de Eichhornia crassipes (flor de agua), en un modelo experimental en ratas. Métodos: Estudio analítico experimental con el empleo 30 ratas macho distribuidas en 3 grupos (n= 10). Grupo I y II; tratadas con el polvo carbonizado de la granada y flor de agua respectivamente. Grupo III: Tratadas con cloruro de sodio al 0,9 por ciento. Se realizó un modelo de herida por escisión en el dorso. La evolución de la cicatrización fue seguida por la velocidad de contracción de la herida en milímetros. Se realizó histología sobre biopsias de tejido cicatrizado. Para el análisis estadístico se empleó la prueba no paramétrica de Mann- Whitney. El nivel de significación se fijó en p < 0,05. Resultados: Se comprobó el efecto cicatrizante de los polvos carbonizados de la granada y flor de agua; disminuyó el área de las heridas de manera significativa respecto al grupo control. El estudio histológico mostró dermis madura grado III en los grupos I y II. Conclusiones: La aplicación tópica del polvo carbonizado de granada y de flor de agua influyó sobre el cierre de las heridas y en la maduración de la dermis, por lo cual favoreció la cicatrización(AU)

ABSTRACT Introduction: Plant species are the first remedy to the people's health problems. The pomegranate is rich in ascorbic acid, improves the epidermal barrier and reduces the contraction of wounds. The water hyacinth has antibacterial activity. Objective: To evaluate the healing effect of the charred powder of Punica granatum Linn (pomegranate) and Eichhornia crassipes (water hyacinth), in an experimental model in rats. Methods: Experimental analytical study with 30 male rats distributed in 3 groups (n = 10). Group I and II; treated with the charred powder of the pomegranate and water hyacinth respectively. Group III: treated with 0.9 percent sodium chloride. An incision wound model was made on the back. The evolution of healing was followed by the speed of contraction of the wound in millimeters. Histology was performed on biopsies of scar tissue. For the statistical analysis, the nonparametric Mann-Whitney test was used. The level of significance was set at p < 0.05. Results: The healing effect of the charred powders of the pomegranate and water hyacinth was verified; decreased the wound area significantly compared to the control group. The histological study showed mature grade III dermis in groups I and II. Conclusions: The topical application of the charred powder of pomegranate and water hyacinth influenced the closure of the wounds and the maturation of the dermis, which favored healing(AU)

Phytochemicals and antidiabetic activity of the aqueous extract of the Punica granatum fruit in streptozotocin-induced diabetic mice.

The present study investigated the phytochemicals and antidiabetic effect of the aqueous extract of the fruit of Punica granatum Linn. in streptozotocin (STZ)-induced diabetic mice. The fruit of P. granatum was extracted with water. The phytochemicals of the water extract were investigated by the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The water extract of P. granatum at doses of 150 and 300 mg/kg body weight (bw) was administered to mice for 21 days, and blood glucose level, triglyceride, total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein-cholesterol, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) enzyme were estimated. Analyzed phytochemicals showed the fruit of P. granatum Linn has a high amount of phenolic and flavonoid compounds, which provide beneficial effect for this plant. The oral administration of the fruit extract of P. granatum at doses of 150 and 300 mg/kg bw for 21 days significantly reduced blood glucose level, triglycerides, serum cholesterol, LDL-cholesterol, AST and ALT enzyme. Our results suggested that the fruit extract of P. granatum has strong antidiabetic effect in STZ-induced diabetic mice. The fruit of this plant might be a potential source of drug for treatment of diabetes.

Potential of pomegranate fruit extract (Punica granatum Linn.) to increase vascular endothelial growth factor and platelet-derived growth factor expressions on the post-tooth extraction wound of Cavia cobaya.

BACKGROUND: Pomegranates fruit extracts have several activities, among others, anti-inflammatory, antibacterial, and antioxidants that have the main content punicalagin and ellagic acid. Pomegranate has the ability of various therapies through different mechanisms. Vascular endothelial growth factor (VEGF) function was to form new blood vessels produced by various cells one of them was macrophages. Platelet-derived growth factor (PDGF) was a growth factor proven chemotactic, increased fibroblast proliferation and collagen matrix production. In addition, VEGF and PDGF synergize in their ability to vascularize tissues. The PDGF function was to stabilize and regulate maturation of new blood vessels. Activities of pomegranate fruit extract were observed by measuring the increased of VEGF and PDGF expression as a marker of wound healing process. AIM: To investigate the potential of pomegranate extracts on the tooth extraction wound to increase the expression of VEGF and PDGF on the 4th day of wound healing process. MATERIALS AND METHODS: This study used 12 Cavia cobaya, which were divided into two groups, namely, the provision of 3% sodium carboxymethyl cellulose and pomegranate extract. The 12 C. cobaya would be executed on the 4th day, the lower jaw of experimental animals was taken, decalcified about 30 days. The expression of VEGF and PDGF was examined using immunohistochemical techniques. The differences of VEGF and PDGF expression were evaluated statistically using t-test. RESULTS: Statistically analysis showed that there were significant differences between control and treatment groups (p<0.05). CONCLUSION: Pomegranate fruit extract administration increased VEGF and PDGF expression on post-tooth extraction wound.

Pomegranate extracts on larval inhibition of Haemonchus spp and Cooperia spp obtained from cattle / Extratos de romã sobre inibição larval de Haemonchus spp e Cooperia spp provenientes de bovinos

Consumers increasingly demand natural food and absent of toxic waste and medicated. The aim of this study was to evaluate the aqueous extract of dried and in natura stem from pomegranate on the larval inhibition of Haemonchus spp. and Cooperia spp. obtained from cattle. Dried and in natura aqueous extract from pomegranate stem (AEPS), negative control (autoclaved distilled water) and positive control (levamisole hydrochloride 0.05 mg / mL) were evaluated. Four mL of each treatment were used, and the results were evaluated in triplicate by egg counts per gram of feces (EPG), larval culture and counting of the larvae. The mean of the larvae that developed per gram of feces was submitted to logarithimic transformation log. (X + 10). The EPG had an average value of 3.620 eggs, identified in larval culture from Haemonchus spp. and Cooperia spp. Dried AEPS presented, by the reduction of larvae, effectiveness of 92.29% for Haemonchus spp. and 96.97% for Cooperia spp. In natura, this extract showed 80% of efficacy against Cooperia larvae, being considered moderately effective; however, for Haemonchus spp. this extract was not effective. These results are specially important for organic and agroecological systems of production, that not allow the use of chemical parasiticides. In conclusion, the use of dried AEPS showed potential anthelmintic and may represent important natural therapeutic option.

Os consumidores têm exigido cada vez mais alimentos naturais e ausentes de resíduos medicamentosos. O objetivo deste estudo foi avaliar o extrato aquoso de caule de romã seco e in natura, sobre a inibição larval de Haemonchus spp. e Cooperia spp. provenientes de bovinos. Foram avaliados extrato aquoso de caule de romã (EACR) seca e in natura, controle negativo (água destilada autoclavada) e controle positivo (cloridrato de levamisol 0,05 mg/mL). Foram utilizados quatro mL de cada tratamento, e os resultados foram avaliados em triplicata, por meio de contagem de ovos por grama de fezes (OPG), cultura de larvas e contagem das larvas. A média de larvas desenvolvidas por grama de fezes foi submetida à transformação logarítmica Log. (x+10). A contagem de OPG apresentou valor médio de 3.620 ovos, sendo identificadas na cultura de larvas de Haemonchus e Cooperia. EACR seca apresentou por meio da redução de larvas, eficácia efetiva de 92,29% para Haemonchus e 96,97% para Cooperia. In natura, este extrato apresentou 80% de eficácia sobre larvas de Cooperia, sendo considerado moderadamente efetivo, porém, para Haemonchus o mesmo não foi efetivo. Esses resultados são especialmente importantes para os sistemas orgânicos e agroecológicos de produção, que não permitem a utilização de parasiticidas químicos. Concluiu-se que a utilização de EACR seca apresentou potencial anti-helmíntico, podendo representar importante opção terapêutica natural.

Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and ß-lactamase producing Klebsiella pneumoniae.

CONTEXT: The global surge in multi-drug resistant bacteria and the imminence of tuberculosis pandemic necessitate alternative therapeutic approaches to augment the existing medications. Pomegranate, the fruit of Punica granatum Linn. (Punicaceae), widely recognized for potency against a broad spectrum of bacterial pathogens, deserves further investigation in this respect. OBJECTIVE: This study determines the therapeutic potential of pomegranate juice, extracts of non-edible peel prepared with methanol/water, and its four polyphenolic constituents, namely caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin, against drug-resistant clinical isolates. MATERIALS AND METHODS: Phenotypic characterisation of Mycobacterium tuberculosis, extended-spectrum ß-lactamase (ESBL) and KPC-type carbapenemase producing Klebsiella pneumoniae was performed by biochemical and molecular methods. Resistance profiles of M. tuberculosis and K. pneumoniae were determined using LJ proportion and Kirby-Bauer methods, respectively. Pomegranate fruit extracts, and the compounds, were evaluated at a dose range of 1024-0.5 µg/mL, and 512-0.25 µg/mL, respectively, to determine minimum inhibitory (MIC) and bactericidal concentrations (MBC) against the drug-resistant isolates by the broth micro-dilution method. RESULTS: The peel extracts exhibited greater antimycobacterial activity (MIC 64-1024 µg/mL) than the potable juice (MIC 256 - > 1024 µg/mL). EGCG and quercetin exhibited higher antitubercular (MIC 32-256 µg/mL) and antibacterial (MIC 64-56 µg/mL) potencies than caffeic acid and ellagic acid (MIC 64-512 µg/mL). DISCUSSION AND CONCLUSION: The pomegranate fruit peel and pure constituents were active against a broad panel of M. tuberculosis and ß-lactamase producing K. pneumoniae isolates. EGCG and quercetin need further investigation for prospective application against respiratory infections.